Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review.
BACKGROUND
The role of adjuvant chemotherapy after resection of colorectal cancers (CRCs) is well understood for patients with stage-I or stage-III disease. Its efficacy for those with stage-II disease remains much less clear. Many investigators have sought to identify prognostic markers that might clarify which patients have the highest risk of recurrence and would, therefore, be most likely to benefit from chemotherapy. This systematic review examines evidence for the use of peripherally sampled, circulating tumour cells (CTCs) as such a prognostic marker.


METHODS
A comprehensive literature search was used to identify studies reporting on the significance of CTCs in the postoperative blood of CRC patients.


RESULTS
Fourteen studies satisfied the inclusion criteria. Six of the nine studies that took blood samples 24 h or more postoperatively found detection of postoperative CTCs to be an independent predictor of cancer recurrence.


CONCLUSIONS
The presence of CTCs in peripheral blood at least 24 h after resection of CRCs is an independent prognostic marker of recurrence. Further studies are needed to clarify the optimal time point for blood sampling and determine the benefit of chemotherapy in CTC-positive patients with stage-II disease.
Peach
G
G
Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, St Mary's Campus, Imperial College London, Praed Street, London W2 1NY, UK. george_peach@hotmail.com
Kim
C
C
Zacharakis
E
E
Purkayastha
S
S
Ziprin
P
P
D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis; D017024:Chemotherapy, Adjuvant / Q000379:methods; D015179:Colorectal Neoplasms / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007633:Keratins / Q000032:analysis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology / Q000473:pathology; D011379:Prognosis; D012008:Recurrence; D016896:Treatment Outcome
D002272:Carcinoembryonic Antigen; D007633:Keratins
Immunol Rev. 2008 Apr;222:145-54
18363999
Int J Cancer. 2004 Jan 10;108(2):219-27
14639606
J Natl Cancer Inst. 1970 Oct;45(4):773-82
5513503
Cancer Lett. 2001 Jan 10;162(1):65-73
11121864
Cancer Res. 2001 Mar 15;61(6):2523-32
11289125
Ann Surg Oncol. 2005 Dec;12(12):988-94
16244799
Int J Cancer. 2008 Nov 1;123(9):1991-2006
18712708
Int J Oncol. 2006 Feb;28(2):297-306
16391782
Br J Cancer. 1998 Apr;77(8):1327-32
9579841
Ann Surg Oncol. 2007 Mar;14(3):1092-8
17200912
Arch Pathol Lab Med. 2000 Jul;124(7):979-94
10888773
Cancer Lett. 2002 Sep 26;183(2):195-203
12065095
Arch Surg. 2002 Sep;137(9):1069-73
12215164
Biochim Biophys Acta. 2009 Dec;1796(2):293-308
19683560
J Surg Res. 2008 Nov;150(1):144-52
18621394
World J Surg. 2004 Jun;28(6):552-7
15366744
Ann Surg. 2002 Dec;236(6):768-75; discussion 775-6
12454515
Surgery. 2006 Apr;139(4):556-62
16627067
Br J Surg. 2003 Jul;90(7):882-8
12854118
Clin Cancer Res. 2008 Nov 15;14(22):7391-6
19010855
Clin Cancer Res. 1999 Dec;5(12):4158-63
10632355
J Surg Res. 2009 Aug;155(2):183-90
19645077
Int J Cancer. 1998 Jun 19;79(3):288-93
9645353
JAMA. 1990 Sep 19;264(11):1444-50
2202842
Ann Surg. 2007 Dec;246(6):1040-6
18043108
Anticancer Res. 2008 Nov-Dec;28(6B):3945-60
19192655
Br J Cancer. 2001 Sep 28;85(7):1047-54
11592778
Br J Surg. 2007 Jan;94(1):96-105
17058316
Ann Surg. 2002 Feb;235(2):226-31
11807362
World J Surg. 2007 Dec;31(12):2329-34
17914651
Int J Clin Oncol. 2006 Oct;11(5):385-9
17058136
J Clin Oncol. 2004 Aug 15;22(16):3408-19
15199089
Ann Surg. 2003 Mar;237(3):368-75
12616121
Int J Oncol. 2006 Feb;28(2):411-20
16391796
Clin Cancer Res. 2007 Apr 15;13(8):2406-13
17406027
Int J Colorectal Dis. 2005 Mar;20(2):137-46
15459772
Int J Cancer. 1997 Oct 21;74(5):540-4
9355978
World J Surg. 2006 Jun;30(6):1007-13
16736329
Lancet. 2007 Dec 15;370(9604):2020-9
18083404
Int J Colorectal Dis. 2001 Jun;16(3):141-6
11459287
BMC Med Res Methodol. 2007 Feb 15;7:10
17302989
Int J Cancer. 2000 Jan 20;89(1):8-13
10719724
Proc R Soc Med. 1976 Jul;69(7):467-9
959220
Cancer. 2000 Sep 1;89(5):970-6
10964326
Int J Cancer. 2006 Jun 15;118(12):3072-7
16425256
World J Gastroenterol. 2005 Jan 21;11(3):436-8
15637763
Gut. 2002 Apr;50(4):530-4
11889075
Clin Cancer Res. 2006 Jan 15;12(2):417-23
16428481
Gastroenterology. 2001 Apr;120(5):1084-92
11266372
Dis Colon Rectum. 1997 Oct;40(10 Suppl):S29-36
9378009
Ann Surg. 2000 Jul;232(1):58-65
10862196
Surgery. 2001 May;129(5):587-94
11331451
Ann Surg Oncol. 2008 Aug;15(8):2120-8
18481151
Ann Surg Oncol. 2008 Nov;15(11):3083-91
18787906
Eur J Cancer. 2007 Dec;43(18):2645-50
17977713
Br J Surg. 2001 Oct;88(10):1307-20
11578283
Nat Rev Cancer. 2004 Jun;4(6):448-56
15170447